Nonalcoholic Fatty Liver Disease

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672

Steatohepatitis: A tale of two “hits”?

Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285

Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions

Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345

Overweight and obesity in the United States: prevalence and trends, 1960–1994

Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045

The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994

Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,973

Nonalcoholic Steatohepatitis

Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994

Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703

IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance

Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078

Non-alcoholic Fatty Liver Disease (NAFLD) as a Neglected Metabolic Companion of Psychiatric Disorders: Common Pathways and Future Approaches

Soto-Angona, Ó., Anmella, G., Valdés-Florido, M. J., De Uribe-Viloria, N., Carvalho, A. F., Penninx, B. W. J. H., & Berk, M. (2020) · BMC Medicine · doi:10.1186/s12916-020-01713-8 · Cited by 122

Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study

Sofi, F., Giangrandi, I., Cesari, F., Corsani, I., Abbate, R., Gensini, G. F., & Casini, A. (2010) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2010.487480 · Cited by 122

Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients

Mariani, S., Fiore, D., Basciani, S., Persichetti, A., Contini, S., Lubrano, C., Salvatori, L., Lenzi, A., & Gnessi, L. (2014) · Endocrine · doi:10.1007/s12020-014-0465-x · Cited by 122

Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men

Ryu, S., Chang, Y., Kim, S. G., Cho, J., & Güallar, E. (2010) · Metabolism · doi:10.1016/j.metabol.2010.08.005 · Cited by 122

Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease

Fujita, K., Nozaki, Y., Wada, K., Yoneda, M., Endo, H., Takahashi, H., Iwasaki, T., Inamori, M., Abe, Y., Kobayashi, N., et al. (2008) · Gut · doi:10.1136/gut.2007.144550 · Cited by 122

Depression and chronic liver diseases: are there shared underlying mechanisms?

Huang, X., Liu, X., & Yu, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00134 · Cited by 121

PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence

Falleti, E., Fabris, C., Cmet, S., Cussigh, A., Bitetto, D., Fontanini, E., Fornasiere, E., Bignulin, S., Fumolo, E., Bignulin, E., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02534.x · Cited by 121

Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats

Wei, Y., Clark, S. E., Morris, E. M., Thyfault, J. P., Uptergrove, G. M., Whaley‐Connell, A. T., Ferrario, C. M., Sowers, J. R., & Ibdah, J. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.018 · Cited by 121

Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients

Chin, K., Nakamura, T., Takahashi, K. P., Sumi, K., Ogawa, Y., Masuzaki, H., Muro, S., Hattori, N., Matsumoto, H., Niimi, A., et al. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01570-x · Cited by 121

Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors

Peng, D., Han, Y., Ding, H., & Wei, L. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05478.x · Cited by 121

Development of Hepatocellular Carcinoma in a Murine Model of Nonalcoholic Steatohepatitis Induced by Use of a High-Fat/Fructose Diet and Sedentary Lifestyle

Dowman, J. K., Hopkins, L., Reynolds, G. M., Nikolaou, N., Armstrong, M. J., Shaw, J. C., Houlihan, D. D., Lalor, P. F., Tomlinson, J., Hübscher, S. G., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.01.034 · Cited by 120

Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy

Asimakopoulou, A., Weiskirchen, S., & Weiskirchen, R. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00430 · Cited by 120

Degradation of splicing factor SRSF3 contributes to progressive liver disease

Kumar, D., Das, M., Sauceda, C., Ellies, L. G., Kuo, K., Parwal, P., Kaur, M., Jih, L., Bandyopadhyay, G. K., Burton, D. W., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127374 · Cited by 120

Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study

Salvi, P., Ruffini, R., Agnoletti, D., Magnani, E., Pagliarani, G., Comandini, G., Praticò, A., Borghi, C., Bénétos, A., & Pazzi, P. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833a7de6 · Cited by 120

Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis

Bechmann, L. P., Gieseler, R. K. H., Sowa, J., Kahraman, A., ERHARD, J., Wedemeyer, I., Emons, B., Jochum, C., Feldkamp, T., Gerken, G., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2010.02248.x · Cited by 120

The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases

Sebastiani, G., Castéra, L., Halfon, P., Pol, S., Mangia, A., Marco, V. D., Pirisi, M., Voiculescu, M., Bourlière, M., & Alberti, A. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04861.x · Cited by 119

Histologic Variation of Grade and Stage of Non-alcoholic Fatty Liver Disease in Liver Biopsies

Janiec, D. J., Jacobson, E. R., Freeth, A., Spaulding, L., & Blaszyk, H. (2005) · Obesity Surgery · doi:10.1381/0960892053723268 · Cited by 119

NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management

Lonardo, A., Mantovani, A., Lugari, S., & Targher, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112841 · Cited by 119

VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation

Mencarelli, A., Cipriani, S., Renga, B., Bruno, A. M., D’Amore, C., Distrutti, E., & Fiorucci, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045425 · Cited by 119

Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: Cause or consequence?

García‐Ruiz, C., Baulies, A., Marí, M., García-Rovés, P. M., & Fernández-Checa, J. C. (2013) · Free Radical Research · doi:10.3109/10715762.2013.830717 · Cited by 119

Clinical trial: insulin‐sensitizing agents may reduce consequences of insulin resistance in individuals with non‐alcoholic steatohepatitis

Idılman, R., Mızrak, D., CORAPCIOGLU, D., Bektaş, M., Doğanay, B., Saykı, M., Çoban, Ş., Erden, E., Soykan, İ., Emral, R., et al. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03723.x · Cited by 119

Gene Expression Profiling Unravels Cancer-Related Hepatic Molecular Signatures in Steatohepatitis but Not in Steatosis

Starmann, J., Fälth, M., Spindelboeck, W., Lanz, K.-L., Lackner, C., Zatloukal, K., Trauner, M., & Sültmann, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046584 · Cited by 119

Dietary phosphatidylcholine alleviates fatty liver induced by orotic acid

Buang, Y., Wang, Y., Cha, J.-Y., Nagao, K., & Yanagita, T. (2005) · Nutrition · doi:10.1016/j.nut.2004.11.019 · Cited by 119

Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis.

Lupșor‐Platon, M., Badea, R., Ştefănescu, H., Grigorescu, M. D., Serban, A., Radu, C., Crișan, D., Sparchez, Z. A., Iancu, S., & Maniu, A. (2010) · PubMed · Cited by 118

NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?

Stols‐Gonçalves, D., Hovingh, G. K., Nieuwdorp, M., & Holleboom, A. G. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.08.008 · Cited by 118

Targeted disruption of GPR7, the endogenous receptor for neuropeptides B and W, leads to metabolic defects and adult-onset obesity

Ishii, M., Fei, H., & Friedman, J. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1334189100 · Cited by 118

Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice

Arsov, T., Larter, C. Z., Nolan, C. J., Petrovsky, N., Goodnow, C. C., Teoh, N., Yeh, M. M., & Farrell, G. C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.032 · Cited by 118

Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice

Malloy, V. L., Perrone, C. E., Mattocks, D. A. L., Ables, G. P., Caliendo, N. S., Orentreich, D. S., & Orentreich∥, N. (2013) · Metabolism · doi:10.1016/j.metabol.2013.06.012 · Cited by 118

Quantification of Liver Fat in the Presence of Iron and Iodine

Fischer, M. A., Gnannt, R., Raptis, D. A., Reiner, C. S., Clavien, P., Schmidt, B. T., Leschka, S., Alkadhi, H., & Goetti, R. P. (2011) · Investigative Radiology · doi:10.1097/rli.0b013e31820e1486 · Cited by 118

The evolving role of liver biopsy

Campbell, M. S., & Reddy, K. R. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02071.x · Cited by 118

Lipid metabolism in hepatic steatosis

Bradbury, M. W., & Berk, P. D. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.005 · Cited by 118

Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels

Dahlhoff, C., Worsch, S., Sailer, M., Hummel, B., Fiamoncini, J., Uebel, K., Obeid, R., Scherling, C., Geisel, J., Bader, B., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.04.010 · Cited by 118

Clinical Syndromes of Alcoholic Liver Disease

Adachi, M., & Brenner, D. A. (2005) · Digestive Diseases · doi:10.1159/000090173 · Cited by 118

MRI: the new reference standard in quantifying hepatic steatosis?

Raptis, D. A., Fischer, M. A., Graf, R., Nanz, D., Weber, A., Moritz, W., Tian, Y., Oberkofler, C. E., & Clavien, P. (2011) · Gut · doi:10.1136/gutjnl-2011-300155 · Cited by 118

Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease

Omer, Z., Çetinkalp, Ş., Akyıldız, M., Yılmaz, F., Batur, Y., Yılmaz, C., & Akarca, U. S. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832e2baf · Cited by 117

Targeting Mitochondrial ROS-Mediated Ferroptosis by Quercetin Alleviates High-Fat Diet-Induced Hepatic Lipotoxicity

Jiang, J., Zhang, G., Zheng, J.-Y., Sun, J., & Ding, S.-B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876550 · Cited by 117

Polyunsaturated Fatty Acid Pattern in Liver and Erythrocyte Phospholipids from Obese Patients

Elizondo, A., Julia Araya, A., Rodrigo, R., Poníachik, J., Csendes, A., Maluenda, F., Díaz, J. C., Signorini, C., Sgherri, C., Comporti, M., et al. (2007) · Obesity · doi:10.1038/oby.2007.518 · Cited by 117

High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism

Longato, L., Tong, M., Wands, J. R., & de la Monte, S. M. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00934.x · Cited by 117

Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets

Lee, Y. M., Choi, J. S., Kim, M. H., Jung, M. H., Lee, Y. S., & Song, J. (2006) · Nutrition · doi:10.1016/j.nut.2005.12.014 · Cited by 116

The Effect of a Silybin-Vitamin E-Phospholipid Complex on Nonalcoholic Fatty Liver Disease: A Pilot Study

Loguercio, C., Federico, A., Trappoliere, M., Tuccillo, C., de Sio, I., Di Leva, A., Niosi, M., D’Auria, M. V., Capasso, R., Blanco, C. D. V., et al. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9703-2 · Cited by 116

The Concentration of Phosphatidylethanolamine in Mitochondria Can Modulate ATP Production and Glucose Metabolism in Mice

van der Veen, J. N., Lingrell, S., da Silva, R. P., Jacobs, R. L., & Vance, D. E. (2014) · Diabetes · doi:10.2337/db13-0993 · Cited by 116

Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice

Honda, T., Ishigami, M., Luo, F., Lingyun, M., Ishizu, Y., Kuzuya, T., Hayashi, K., Nakano, I., Ishikawa, T., Feng, G., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.013 · Cited by 116

From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications

Boccatonda, A., Andreetto, L., D’Ardes, D., Cocco, G., Rossi, I., Vicari, S., Schiavone, C., Cipollone, F., & Guagnano, M. T. (2023) · Biomedicines · doi:10.3390/biomedicines11030883 · Cited by 116

Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis

Lo, L. W.-Y., McLennan, S. V., Williams, P. F., Bonner, J. G., Chowdhury, S., McCaughan, G. W., Gorrell, M. D., Yue, D. K., & Twigg, S. M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.039 · Cited by 116

Adiponectin, hepatocellular dysfunction and insulin sensitivity

López‐Bermejo, A., Botas, P., Funahashi, T., Delgado, E., Kihara, S., Ricart, W., & Fernández‐Real, J. M. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2004.01977.x · Cited by 116

Imaging Features of Perivascular Fatty Infiltration of the Liver: Initial Observations

Hamer, O. W., Aguirre, D. A., Casola, G., & Sirlin, C. B. (2005) · Radiology · doi:10.1148/radiol.2371041580 · Cited by 116

Using controlled clinical trials to learn more about acute drug-induced liver injury

Watkins, P. B., Seligman, P. J., Pears, J. S., Avigan, M., & Senior, J. R. (2008) · Hepatology · doi:10.1002/hep.22633 · Cited by 116

The role of autophagy in liver cancer: Molecular mechanisms and potential therapeutic targets

Cui, J., Gong, Z., & Shen, H. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.02.003 · Cited by 116

The Inflamed Liver and Atherosclerosis: A Link Between Histologic Severity of Nonalcoholic Fatty Liver Disease and Increased Cardiovascular Risk

Alkhouri, N., Tamimi, T., Yerian, L. M., López, R., Zein, N. N., & Feldstein, A. E. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1075-y · Cited by 116

Long term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease

Hafliðadóttir, S., Jonasson, J. G., Norland, H., Einarsdottir, S., Kleiner, D. E., Lund, S. H., & Bjornsson, E. S. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-166 · Cited by 116

Demystifying the management of hypertriglyceridaemia

Watts, G. F., Ooi, E. M. M., & Chan, D. C. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.140 · Cited by 115

Nuclear Receptors as New Perspective for the Management of Liver Diseases

Trauner, M., & Halilbasic, E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.044 · Cited by 115

Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice

Park, S., Choi, Y., Um, S., Yoon, S. K., & Park, T. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.019 · Cited by 115

Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats

Ma, Z., Chu, L., Liu, H., Wang, W., Li, J., Yao, W., Yi, J., & Gao, Y. (2017) · Scientific Reports · doi:10.1038/srep44819 · Cited by 115

Non‐alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle‐aged adults: The Framingham Study

Weinstein, G., Davis‐Plourde, K. L., Himali, J. J., Zelber‐Sagi, S., Beiser, A., & Seshadri, S. S. (2019) · Liver International · doi:10.1111/liv.14161 · Cited by 115

Curcumin analog CUR5–8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity

Lee, E. S., Kwon, M.-H., Kim, H. M., Woo, H. B., Ahn, C. M., & Chung, C. H. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154015 · Cited by 115

Diagnosis and management of non‐alcoholic fatty liver disease and related metabolic disorders: Consensus statement from the S tudy G roup of L iver and M etabolism, C hinese S ociety of E ndocrinology (非酒精性脂肪性肝病与相关代谢紊乱诊疗共识——中华医学会内分泌学分会肝病与代谢学组)

Gao, X., Fan, J., & Study Group of Liver and Metabolism, C. S. O. E. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12056 · Cited by 115

Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease

Targher, G., Bertolini, L., Rodella, S., Zoppini, G., Zenari, L., & Falezza, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02466.x · Cited by 115

Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH

Yoshioka, Y., Hashimoto, E., Yatsuji, S., Kaneda, H., Taniai, M., Tokushige, K., & Shiratori, K. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-004-1475-x · Cited by 115

High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats

Meli, R., Raso, G. M., Irace, C., Simeoli, R., Pascale, A. D., Paciello, O., Pagano, T. B., Calignano, A., Colonna, A., & Santamaria, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066570 · Cited by 115

Triglycerides to high‐density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population‐based cohort study

Fukuda, Y., Hashimoto, Y., Hamaguchi, M., Fukuda, T., Nakamura, N., Ohbora, A., Kato, T., Kojima, T., & Fukui, M. (2015) · Liver International · doi:10.1111/liv.12977 · Cited by 114

Early maternal undernutrition programs increased feed intake, altered glucose metabolism and insulin secretion, and liver function in aged female offspring

George, L. A., Zhang, L., Tuersunjiang, N., Ma, Y., Long, N., Uthlaut, A. B., Smith, D. T., Nathanielsz, P. W., & Ford, S. P. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00241.2011 · Cited by 114

Bariatric Surgery and Liver Transplantation: a Systematic Review a New Frontier for Bariatric Surgery

Lazzati, A., Iannelli, A., Schneck, A.-S., Charles‐Nelson, A., Katsahian, S., Gugenheim, J., & Azoulay, D. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1430-8 · Cited by 114

The effect of green tea extract supplementation on liver enzymes in patients with nonalcoholic fatty liver disease

Askari, G., Pezeshki, A., Safi, S., Feizi, A., & Karami, F. (2016) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.173051 · Cited by 114

Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions

Loomba, R. S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.028 · Cited by 114

Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non‐alcoholic fatty liver disease complicated by diabetes mellitus

Akuta, N., Kawamura, Y., Watanabe, C., Nishimura, A., Okubo, M., Mori, Y., Fujiyama, S., Sezaki, H., Hosaka, T., Kobayashi, M., et al. (2018) · Hepatology Research · doi:10.1111/hepr.13304 · Cited by 114

Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study

Trombetta, M., Spiazzi, G., Zoppini, G., & Muggeo, M. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02590.x · Cited by 114

Nonalcoholic Fatty Liver Disease

Kopec, K. L., & Burns, D. L. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533611419668 · Cited by 114

Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.

Georgescu, E. F., & Georgescu, M. (2007) · PubMed · Cited by 114

Cardiovascular Fat, Menopause, and Sex Hormones in Women: The SWAN Cardiovascular Fat Ancillary Study

Khoudary, S. R. E., Shields, K. J., Janssen, İ., Hanley, C. L., Budoff, M. J., Barinas‐Mitchell, E., Everson‐Rose, S. A., Powell, L. H., & Matthews, K. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2110 · Cited by 113

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach

Alisi, A., Feldstein, A. E., Villani, A., Raponi, M., & Nobili, V. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.273 · Cited by 113

SREBP-1c overexpression induces triglycerides accumulation through increasing lipid synthesis and decreasing lipid oxidation and VLDL assembly in bovine hepatocytes

Li, X., Li, Y., Yang, W., Xiao, C., Fu, S., Deng, Q., Ding, H., Wang, Z., Liu, G., & Li, X. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.02.009 · Cited by 113

Gut–liver on a chip toward an in vitro model of hepatic steatosis

Lee, S. Y., & Sung, J. H. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26793 · Cited by 113

Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view

Bessone, F., Dirchwolf, M., Rodil, M. A., Razori, M. V., & Roma, M. G. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14952 · Cited by 113

Resolvin D1 primes the resolution process initiated by calorie restriction in obesity‐induced steatohepatitis

Rius, B., Titos, E., Morán‐Salvador, E., López‐Vicario, C., García‐Alonso, V., González‐Périz, A., Arroyo, V., & Clària, J. (2013) · The FASEB Journal · doi:10.1096/fj.13-235614 · Cited by 113

Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease

Alkhouri, N., Sedki, E., Alisi, A., López, R., Pinzani, M., Feldstein, A. E., & Nobili, V. (2012) · Liver International · doi:10.1111/liv.12024 · Cited by 113

The Clinicopathological Profile of Indian Patients with Nonalcoholic Fatty Liver Disease (NAFLD) is Different from That in the West

Duseja, A. K., Das, A., Das, R., Dhiman, R. K., Chawla, Y. K., Bhansali, A. K., & Kalra, N. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9136-y · Cited by 113

Inhibition of ADRP prevents diet-induced insulin resistance

Varela, G. M., Antwi, D. A., Dhir, R. N., Yin, X., Singhal, N. S., Graham, M. J., Crooke, R. M., & Ahima, R. S. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90204.2008 · Cited by 113

Non-alcoholic fatty liver disease: an emerging pathological spectrum

Zafrani, É. S. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0943-7 · Cited by 113

5-Lipoxygenase Deficiency Reduces Hepatic Inflammation and Tumor Necrosis Factor α–Induced Hepatocyte Damage in Hyperlipidemia-Prone Apoe-Null Mice

Martínez‐Clemente, M., Ferré, N., González‐Périz, A., López‐Parra, M., Horrillo, R., Titos, E., Morán‐Salvador, E., Miquel, R., Arroyo, V., Funk, C. D., et al. (2009) · Hepatology · doi:10.1002/hep.23463 · Cited by 113

Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: A possible role for SirT3 activation

Teodoro, J. S., Duarte, F. V., Gomes, A. P., Varela, A. T. I. F., Peixoto, F., Rolo, A. P., & Palmeira, C. M. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.09.002 · Cited by 112

Liver disease and diabetes: Association, pathophysiology, and management

Ahmadieh, H., & Azar, S. T. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.01.003 · Cited by 112

Role of lipid droplet proteins in liver steatosis

Okumura, T. (2011) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-011-0110-6 · Cited by 112

MR Spectroscopy of the Liver: Principles and Clinical Applications

Qayyum, A. (2009) · Radiographics · doi:10.1148/rg.296095520 · Cited by 112

Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion

de Oliveira, P. R. B., da Costa, C. A., de Bem, G. F., Cordeiro, V. S. C., Santos, I. B., de Carvalho, L., da Conceição, E. P. S., Lisboa, P. C., Ognibene, D. T., Sousa, P. J. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143721 · Cited by 112

Fatty Acids - Induced Lipotoxicity and Inflammation

Savary, S., Trompier, D., Andreoletti, P., Le Borgne, F., Demarquoy, J., & Lizard, G. (2012) · Current Drug Metabolism · doi:10.2174/138920012803762729 · Cited by 111

Increased selenoprotein P levels in subjects with visceral obesity and nonalcoholic Fatty liver disease

Choi, H. Y., Hwang, S. Y., Lee, C. H., Hong, H. C., Yang, S. J., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.1.63 · Cited by 111

Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease

Higuchi, N., Kato, M., Tanaka, M., MIYAZAKI, M., TAKAO, S., Kohjima, M., Kotoh, K., Enjoji, M., Nakamuta, M., & Takayanagi, R. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.328 · Cited by 111

Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation

Chow, J. D. Y., Lawrence, R., Healy, M. E., Dominy, J. E., Liao, J. A., Breen, D. S., Byrne, F. L., Kenwood, B. M., Lackner, C., Okutsu, S., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.004 · Cited by 111

Bax inhibitor‐1 protects from nonalcoholic steatohepatitis by limiting inositol‐requiring enzyme 1 alpha signaling in mice

Lebeaupin, C., Vallée, D., Rousseau, D., Patouraux, S., Bonnafous, S., Adam, G., Luciano, F., Luci, C., Anty, R., Iannelli, A., et al. (2018) · Hepatology · doi:10.1002/hep.29847 · Cited by 111

MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis

Wang, X., Shi, L., Wang, X., Feng, Y., & Wang, Y. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.007 · Cited by 111

Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus‐infected and hepatitis C virus‐cleared patients

Imazeki, F., Yokosuka, O., Fukai, K., Kanda, T., Kojima, H., & Saisho, H. (2008) · Liver International · doi:10.1111/j.1478-3231.2007.01630.x · Cited by 111

Mitochondrial involvement in non-alcoholic steatohepatitis

Serviddio, G., Sastre, J., Bellanti, F., Viña, J., Vendemiale, G., & Altomare, E. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.014 · Cited by 111

Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease

Mendes, F. D., Suzuki, A., Sanderson, S. O., Lindor, K. D., & Angulo, P. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.05.008 · Cited by 111

New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)

Ali, R., & Cusi, K. J. (2009) · Annals of Medicine · doi:10.1080/07853890802552437 · Cited by 111

Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload

Barisani, D., Pelucchi, S., Mariani, R., Galimberti, S., Trombini, P., Fumagalli, D., Meneveri, R., Nemeth, E., Ganz, T., & Piperno, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.011 · Cited by 111

Association between psychological distress and liver disease mortality: A meta-analysis of individual study participants

Russ, T. C., Kivimäki, M., Morling, J. R., Starr, J. M., Stamatakis, E., & Batty, G. D. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.004 · Cited by 110

Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model

de Meijer, V. E., Le, H. D., Meisel, J. A., Sharif, M. R. A., Pan, A., Nosé, V., & Puder, M. (2010) · Metabolism · doi:10.1016/j.metabol.2009.11.006 · Cited by 110

Association between nonalcoholic fatty liver disease and coronary artery disease

Arslan, U., Türkoğlu, S., Balcıoğlu, S., Tavıl, Y., Karakan, T., & Çengel, A. (2007) · Coronary Artery Disease · doi:10.1097/mca.0b013e3282583c0d · Cited by 110

Non‐alcoholic fatty liver disease: Further expression of the metabolic syndrome

Tarantino, G., Saldalamacchia, G., Conca, P., & Arena, A. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04824.x · Cited by 184

Nonalcoholic fatty liver disease is associated with hyperlipidemia and obesity

Sharabi, Y., & Eldad, A. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00434-4 · Cited by 41

Non alcoholic fatty liver disease : original

Coetzee, A., & Ascott-Evans, B. (2015) · South African Journal of Diabetes

Nonobese Nonalcoholic Fatty Liver Disease: An Important Clinical Entity

Zaman, A. (2016) · Journal watch · doi:10.1056/nejm-jw.na42300

Nicht alkoholische Fettleberkrankheit (NAFLK)

Keller, K. (2004) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-004-0995-z · Cited by 1